東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Thyroid cancer = from emergent biote...

Carpi, A.

Linked to FindBook

Google Book

Amazon

博客來

Thyroid cancer = from emergent biotechnologies to clinical practice guidelines /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Thyroid cancer/ editors, Angelo Carpi, Jeffrey I. Mechanick.
Reminder of title:	from emergent biotechnologies to clinical practice guidelines /
other author:	Carpi, A.
Published:	Boca Raton :CRC Press/Taylor & Francis, : c2011.,
Description:	1 online resource (xvii, 390 p.) :ill.
Notes:	"A CRC title."
Subject:	Thyroid gland - Cancer. -
Online resource:	http://www.crcnetbase.com/isbn/9781439862216
ISBN:	9781439862223 (electronic bk.)

Thyroid cancer = from emergent biotechnologies to clinical practice guidelines /
Thyroid cancerfrom emergent biotechnologies to clinical practice guidelines /[electronic resource] :editors, Angelo Carpi, Jeffrey I. Mechanick. - Boca Raton :CRC Press/Taylor & Francis,c2011. - 1 online resource (xvii, 390 p.) :ill.

"A CRC title."

Includes bibliographical references and index.

"Thyroid cancer evaluation and treatment has enjoyed very little evolution in comparison with other disease management strategies. The standard treatment algorithms for thyroid cancer have varied only in response to major, though infrequent, biotechnological innovations. These resultant algorithm node insertions produced paradigm changes, but there has been little to advance the care of the patient with advanced thyroid cancer--until very recently. Perhaps the reasons for a relative lack of interest and scientific progress are the overwhelming likelihood of benignity among thyroid nodules, the overwhelmingly favorable clinical outcome even if a patient has thyroid cancer, and the overwhelming long time required for clinical follow-up of these cancer patients. Unfortunately, the problem now is that we may be overmanaging low-risk patients, and we have not achieved the clinical responses we would have liked with high-risk patients"--Provided by publisher.

ISBN: 9781439862223 (electronic bk.)Subjects--Topical Terms:

894671
Thyroid gland
--Cancer.Index Terms--Genre/Form:

542853
Electronic books.

LC Class. No.: RC280.T6 / T534 2011eb

Dewey Class. No.: 616.99/444

National Library of Medicine Call No.: 2011 H-129

Thyroid cancer = from emergent biotechnologies to clinical practice guidelines /
LDR:01951cmm a2200289Ka 4500 001 1901971
006 m o d
007 cr cnu---unuuu
008 240124s2011 flua ob 001 0 eng d
020 $a 9781439862223 (electronic bk.)
020 $a 1439862222 (electronic bk.)
020 $z 9781439862216
020 $z 1439862214
035 $a ocn755599117
035 $a 1901971
040 $a N $c N $d YDXCP $d OCLCQ
050 4 $a RC280.T6 $b T534 2011eb
060 1 4 $a 2011 H-129
060 1 4 $a WK 270
082 0 4 $a 616.99/444 $2 23
245 0 0 $a Thyroid cancer $h [electronic resource] : $b from emergent biotechnologies to clinical practice guidelines / $c editors, Angelo Carpi, Jeffrey I. Mechanick.
260 $a Boca Raton : $b CRC Press/Taylor & Francis, $c c2011.
300 $a 1 online resource (xvii, 390 p.) : $b ill.
500 $a "A CRC title."
504 $a Includes bibliographical references and index.
520 $a "Thyroid cancer evaluation and treatment has enjoyed very little evolution in comparison with other disease management strategies. The standard treatment algorithms for thyroid cancer have varied only in response to major, though infrequent, biotechnological innovations. These resultant algorithm node insertions produced paradigm changes, but there has been little to advance the care of the patient with advanced thyroid cancer--until very recently. Perhaps the reasons for a relative lack of interest and scientific progress are the overwhelming likelihood of benignity among thyroid nodules, the overwhelmingly favorable clinical outcome even if a patient has thyroid cancer, and the overwhelming long time required for clinical follow-up of these cancer patients. Unfortunately, the problem now is that we may be overmanaging low-risk patients, and we have not achieved the clinical responses we would have liked with high-risk patients"--Provided by publisher.
588 $a Description based on print version record.
650 0 $a Thyroid gland $x Cancer. $3 894671
650 1 2 $a Thyroid Neoplasms $x diagnosis. $3 2017190
650 1 2 $a Thyroid Neoplasms $x therapy. $3 1362199
655 4 $a Electronic books. $2 lcsh $3 542853
700 1 $a Carpi, A. $q (Angelo) $3 3652228
700 1 $a Mechanick, Jeffrey I. $3 916446
856 4 0 $u http://www.crcnetbase.com/isbn/9781439862216